Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses
Description
Monoclonal antibodies that retain neutralizing activity against multiple coronavirus (CoV) lineages and variants of concern (VoC) must be developed to protect against future pandemics. These broadly neutralizing MAbs (BNMAbs) may be used as
